Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Cost effectiveness of contraceptives in the United States.

Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J.

Contraception. 2009 Jan;79(1):5-14. doi: 10.1016/j.contraception.2008.08.003. Epub 2008 Sep 25. Erratum in: Contraception. 2009 Aug;80(2):229-30.

2.

Update on and correction to the cost-effectiveness of contraceptives in the United States.

Trussell J.

Contraception. 2012 Jun;85(6):611. doi: 10.1016/j.contraception.2012.02.009. Epub 2012 Mar 27. No abstract available.

PMID:
22459232
3.

Update on and correction to the cost effectiveness of contraceptives in the United States.

Trussell J.

Contraception. 2012 Feb;85(2):218. doi: 10.1016/j.contraception.2011.06.011. Epub 2011 Aug 12. No abstract available.

PMID:
22067776
4.
5.

Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception.

Trussell J, Hassan F, Henry N, Pocoski J, Law A, Filonenko A.

Contraception. 2014 May;89(5):451-9. doi: 10.1016/j.contraception.2013.10.019. Epub 2014 Jan 24.

6.

Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.

Heinemann K, Reed S, Moehner S, Minh TD.

Contraception. 2015 Apr;91(4):280-3. doi: 10.1016/j.contraception.2015.01.011. Epub 2015 Jan 16.

7.
8.

Budget impact analysis of 8 hormonal contraceptive options.

Crespi S, Kerrigan M, Sood V.

Am J Manag Care. 2013 Jul 1;19(7):e249-55.

9.

Economic analysis of contraceptives for women.

Chiou CF, Trussell J, Reyes E, Knight K, Wallace J, Udani J, Oda K, Borenstein J.

Contraception. 2003 Jul;68(1):3-10.

PMID:
12878280
10.

Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.

Bahamondes L, Bottura BF, Bahamondes MV, Gonçalves MP, Correia VM, Espejo-Arce X, Sousa MH, Monteiro I, Fernandes A.

Hum Reprod. 2014 Oct 10;29(10):2163-70. doi: 10.1093/humrep/deu191. Epub 2014 Aug 1.

PMID:
25085802
11.

Achieving cost-neutrality with long-acting reversible contraceptive methods.

Trussell J, Hassan F, Lowin J, Law A, Filonenko A.

Contraception. 2015 Jan;91(1):49-56. doi: 10.1016/j.contraception.2014.08.011. Epub 2014 Sep 6.

12.

Hormonal and intrauterine methods for contraception for women aged 25 years and younger.

Krashin J, Tang JH, Mody S, Lopez LM.

Cochrane Database Syst Rev. 2015 Aug 17;(8):CD009805. doi: 10.1002/14651858.CD009805.pub3. Review.

PMID:
26280888
13.

Estimated economic impact of the levonorgestrel intrauterine system on unintended pregnancy in active duty women.

Heitmann RJ, Mumford SL, Hill MJ, Armstrong AY.

Mil Med. 2014 Oct;179(10):1127-32. doi: 10.7205/MILMED-D-14-00055.

PMID:
25269131
14.

Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden.

Henry N, Hawes C, Lowin J, Lekander I, Filonenko A, Kallner HK.

Acta Obstet Gynecol Scand. 2015 Aug;94(8):884-90. doi: 10.1111/aogs.12679. Epub 2015 Jun 17.

15.

A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.

Bahamondes L, Brache V, Meirik O, Ali M, Habib N, Landoulsi S; WHO Study Group on Contraceptive Implants for Women.

Hum Reprod. 2015 Nov;30(11):2527-38. doi: 10.1093/humrep/dev221. Epub 2015 Sep 25.

16.

The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.

Ganz ML, Shah D, Gidwani R, Filonenko A, Su W, Pocoski J, Law A.

Value Health. 2013 Mar-Apr;16(2):325-33. doi: 10.1016/j.jval.2012.11.011.

17.

Intrauterine devices. The optimal long-term contraceptive method?

Fortney JA, Feldblum PJ, Raymond EG.

J Reprod Med. 1999 Mar;44(3):269-74. Review.

PMID:
10202746
18.

[Information on advances in sciences and technology. Advances in contraceptive technology].

Andrade AT.

Bol Cent Biol Reprod. 1993;12(1):51-2. Portuguese.

PMID:
12345521
19.

Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.

French R, Van Vliet H, Cowan F, Mansour D, Morris S, Hughes D, Robinson A, Proctor T, Summerbell C, Logan S, Helmerhorst F, Guillebaud J.

Cochrane Database Syst Rev. 2004;(3):CD001776. Review.

PMID:
15266453
20.

Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception.

Blumenthal PD, Trussell J, Singh RH, Guo A, Borenstein J, Dubois RW, Liu Z.

Contraception. 2006 Sep;74(3):249-58. Epub 2006 May 23. Review.

PMID:
16904420

Supplemental Content

Support Center